Pankaj Singh

Title: Pankaj Singh: Innovator in Tumor-Infiltrating Lymphocyte Quantification

Introduction

Pankaj Singh is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of clinical pathology through his innovative patent. His work focuses on the quantification of tumor-infiltrating lymphocytes (TILs), which plays a crucial role in cancer diagnosis and treatment.

Latest Patents

Pankaj Singh holds a patent for a system and method to quantify tumor-infiltrating lymphocytes for clinical pathology analysis. The patent describes a system that quantifies the density level of TILs based on the prediction of reconstructed TIL information associated with tumoral tissue image data. This system processes digitized diagnostic and stained whole-slide image data related to specific types of tumors. It defines regions of interest within the image data and encodes this data into segmented portions using convolutional autoencoding techniques. The system determines the density of TILs in these segmented data portions and assigns classification labels based on a pre-determined threshold probability value. The threshold can be adjusted to refine the classification process, allowing for improved sensitivity in detecting lymphocyte infiltration. A trained classification model is then used to classify unlabeled image data iteratively, generating refined representations of TILs.

Career Highlights

Pankaj Singh has worked with prestigious institutions such as the State University of New York and the University of Texas System. His experience in these organizations has contributed to his expertise in the field of pathology and image analysis.

Collaborations

Some of Pankaj Singh's notable coworkers include Joel Haskin Saltz and Tahsin M Kurc. Their collaborative efforts have likely enhanced the development and application of his innovative systems.

Conclusion

Pankaj Singh's contributions to the quantification of tumor-infiltrating lymphocytes represent a significant advancement in clinical pathology. His innovative patent showcases the potential for improved cancer diagnostics and treatment strategies.